Dr. Jonas Leibowitz
My Diabetes Doc
My Diabetes Doc is the podcast that makes diabetes care easier to understand. Hosted by endocrinologist Dr. Jonas Leibowitz, each episode delivers expert insights, practical tips, and the latest advances in diabetes treatment, nutrition, weight management, and metabolic health. Whether you're living with diabetes, caring for someone who is, or looking to improve your health, you'll gain trusted, evidence-based guidance to help you live better and healthier.
N'hésitez pas à visiter le site du podcast et à soutenir son créateur : podcasters.spotify.com
Auteur
Dr. Jonas Leibowitz
Catégorie
Site du podcast
Dernier épisode
7 oct. 2026
Où écouter ?
Les podcasts dans l'appli Replaio Radio Bientôt disponibleLes podcasts arrivent très bientôt dans l'appli. Installe-la dès maintenant et découvre en avant-première une toute nouvelle façon de vivre les podcasts
Épisodes
What Happens If You Miss Multiple GLP-1 Doses? 07.10.2026 3:28
What happens if you miss multiple doses of your GLP-1 medication? In this episode of My Diabetes Doc , Dr. Jonas discusses what can happen when patients go several weeks without their GLP-1 medication and why restarting may require a different approach. Missed doses can happen for many reasons, including travel, medical procedures, surgery, pharmacy or insurance issues, running out of medication,...
Understanding GLP-1: Incretins, GIP & How GLP-1 Was Discovered 04.09.2026 4:00
In this episode, I answer three important questions about GLP-1 medications and incretin hormones. First, what is an incretin? I explain how incretin hormones connect food intake with insulin release, blood sugar control, appetite, and the way food moves through the digestive system. I also break down the four major effects associated with GLP-1. Next, I explain what GIP is and why it is becoming...
2 Major Mounjaro Updates Every Diabetes Patient Should Know 01.09.2026 2:25
In this episode of the My Diabetes Doc Podcast, Dr. Jonas shares two important updates about Mounjaro (tirzepatide), a GLP-1 and GIP medication used in the treatment of type 2 diabetes. First, Dr. Jonas discusses Mounjaro's new cardiovascular indication for certain patients with type 2 diabetes who are at high risk for cardiovascular disease. He explains recent data comparing Mounjaro with Tru...
Medicare GLP-1 Bridge Program: Issues with Qualifying for the Program 30.08.2026 5:05
The Medicare GLP-1 Bridge Program was designed to help expand access to certain weight loss medications for eligible Medicare recipients—but qualifying for the program may not always be as straightforward as expected. In this episode of My Diabetes Doc , endocrinologist Dr. Jonas Leibowitz discusses some of the eligibility issues patients may encounter with the Medicare GLP-1 Bridge Program. Dr. L...
Zepbound Explained: How It Works, How It’s Dosed & What Patients Should Know 28.08.2026 4:25
How does Zepbound® work, and how is it dosed? In this episode of My Diabetes Doc, Dr. Jonas Leibowitz, an endocrinologist, provides a physician-led overview of Zepbound (tirzepatide), one of the medications included in the Medicare GLP-1 Bridge Program for weight management. In Part 1, Dr. Leibowitz explains how Zepbound works and why it is different from medications that target GLP-1 alone. Zepbo...
Wegovy Injection: Summary of what to expect - Medicare GLP-1 Bridge Program 20.08.2026 2:07
In this episode of the My Diabetes Doc Podcast , Dr. Jonas Leibowitz, an endocrinologist with 30 years of experience, provides an overview of the Wegovy injection and what patients should know before beginning treatment through the new Medicare Bridge weight-loss program. Dr. Jonas explains how Wegovy works as a GLP-1 receptor agonist, reviews the available dosing options, and discusses the amount...
Wegovy Injection: Weight Loss Effect & Side effects 18.08.2026 4:20
In this episode, I discuss the Wegovy injection, a GLP-1 medication for weight loss, which is part of the new Medicare Bridge program that started on July 1, 2026. In the first part of this episode, I discuss the weight-loss effects you can expect from this medication, and in the second part, I discuss the side effects associated with taking the Wegovy injection. The weight loss data is based on t...
Introducing the Wegovy Injection & Explaining dosing. Covered under the Medicare GLP-1 Bridge Program 13.08.2026 3:05
Dr. Jonas Leibowitz, an endocrinologist with 30 years of experience, introduces Wegovy, a GLP-1 receptor agonist and one of four medications covered by the new Medicare weight loss program starting July 1, 2026. Wegovy, similar to Ozempic, helps with weight loss by stimulating appetite suppression and regulating blood sugar levels. It comes in six doses, starting from 0.25 mg and increasing up to...
Do You Qualify for Medicare's New GLP-1 Weight Loss Program? 17.07.2026 5:33
Who qualifies for the new Medicare Bridge GLP-1 Weight Loss Program? In this episode, Dr. Jonas Leibowitz, an endocrinologist with more than 30 years of experience, explains the eligibility requirements for Medicare beneficiaries seeking GLP-1 weight loss medications through the new Bridge Program. Dr. Leibowitz reviews the BMI thresholds, qualifying medical conditions, and the four medications in...
I just found out I have type 2 diabetes, and I have symptoms 12.06.2026 6:49
What should you do if you've just been diagnosed with Type 2 diabetes and you're already experiencing symptoms? In this episode, endocrinologist Dr. Jonas Leibowitz draws on more than 30 years of clinical experience to explain what happens when Type 2 diabetes presents with symptoms such as excessive thirst, frequent urination, weight loss, blurry vision, and increased hunger. He breaks do...
I have been diagnosed with diabetes, now what? 29.05.2026 12:14
I Just Found Out I Have Type 2 Diabetes—Now What? Being diagnosed with Type 2 diabetes can feel overwhelming, but understanding what comes next is the first step toward taking control of your health. In this episode of My Diabetes Doc , endocrinologist Dr. Jonas Leibowitz draws on more than 30 years of experience to explain what a new diagnosis of Type 2 diabetes really means and how patients can...
Podcasts similaires
Replaio n'est pas éditeur de podcasts ; les noms des émissions, les visuels et l'audio appartiennent à leurs auteurs et sont diffusés via des flux RSS publics